Second-line Treatment of HIV-1 With Ritonavir Boosted Atazanavir or Darunavir With an Optimized NRTI Backbone
Clinical trial NCT01605084 · WITHDRAWN
Trial details
- NCT number
- NCT01605084
- Sponsor
- Bristol-Myers Squibb
- Status
- WITHDRAWN
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2012-06-30
- Primary completion
- 2014-08-31
- Enrollment
- 0
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.